Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
UnitedHealth
UNH
5
Tesla
TSLA
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 7.08%26.4B | 6.35%23.67B | 1.97%93.28B | 0.42%23.82B | 3.88%24.65B | 0.17%22.56B | 3.48%22.25B | 10.89%91.47B | 9.43%23.72B | 9.92%23.73B |
Cost of revenue | 7.99%19.31B | 6.30%17.22B | 0.48%67.82B | -2.27%17.25B | 2.36%17.88B | -0.97%16.49B | 3.00%16.2B | 13.11%67.5B | 10.83%17.66B | 11.62%17.47B |
Gross profit | 4.70%7.09B | 6.51%6.45B | 6.18%25.45B | 8.23%6.56B | 8.10%6.77B | 3.41%6.07B | 4.78%6.05B | 5.10%23.97B | 5.53%6.06B | 5.44%6.26B |
Operating expense | 6.54%5.16B | 4.02%4.92B | 4.56%19.71B | 10.42%5.36B | 1.15%4.85B | 2.82%4.77B | 3.68%4.73B | 4.22%18.85B | 2.52%4.86B | 5.89%4.79B |
Staff costs | ---- | ---- | 2.96%6.99B | ---- | ---- | ---- | ---- | 2.97%6.79B | ---- | ---- |
Selling and administrative expenses | ---- | ---- | 1.60%5.2B | ---- | ---- | ---- | ---- | 1.23%5.12B | ---- | ---- |
-General and administrative expense | ---- | ---- | 1.60%5.2B | ---- | ---- | ---- | ---- | 1.23%5.12B | ---- | ---- |
Depreciation and amortization | ---- | ---- | 7.15%1.5B | ---- | ---- | ---- | ---- | 28.59%1.4B | ---- | ---- |
-Depreciation | ---- | ---- | 7.15%1.5B | ---- | ---- | ---- | ---- | 28.59%1.4B | ---- | ---- |
Rent and land expenses | ---- | ---- | 15.49%1.1B | ---- | ---- | ---- | ---- | -7.50%949M | ---- | ---- |
Other operating expenses | ---- | ---- | 7.18%4.92B | ---- | ---- | ---- | ---- | 6.28%4.59B | ---- | ---- |
Operating profit | 0.05%1.92B | 15.40%1.53B | 12.15%5.74B | -0.58%1.2B | 30.73%1.92B | 5.62%1.3B | 8.87%1.33B | 8.46%5.12B | 19.71%1.21B | 3.99%1.47B |
Net non-operating interest income (expenses) | 0.00%-11M | -22.22%-11M | 69.23%-4M | 1,000.00%22M | -83.33%-11M | -50.00%-6M | -80.00%-9M | -8.58%-13M | 107.90%2M | -25.23%-6M |
Non-operating interest income | 200.00%6M | 50.00%3M | 175.00%44M | 260.00%36M | 0.00%2M | 33.33%4M | 100.00%2M | 35.71%16M | 35.24%10M | 100.60%2M |
Non-operating interest expense | 30.77%17M | 27.27%14M | 65.52%48M | 75.00%14M | 62.50%13M | 42.86%10M | 83.33%11M | 22.04%29M | 24.38%8M | 38.22%8M |
Net investment income | 888.57%346M | -7.29%267M | 56.00%546M | 1,733.33%147M | 168.63%35M | -29.63%76M | -4.64%288M | -10.25%350M | -109.54%-9M | -134.61%-51M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 349.04%467M | 0 | 28.95%196M | -157.58%-19M | -12.61%104M | 0 | 111M | -82.55%152M | -92.24%33M | 119M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -89.41%-322M | -438.18%-296M | 40.00%-12M | 92.06%-5M | 71.88%-9M | -39.16%-170M | -625.88%-55M | 66.37%-20M | ||
Less:Other special charges | ---- | ---- | -70.59%50M | -56.36%24M | -40.00%12M | -92.06%5M | -71.88%9M | 39.16%170M | 625.88%55M | -66.37%20M |
Less:Write off | ---- | ---- | --272M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Other non-operating income (expenses) | -89.44%15M | 82.19%266M | -1.90%516M | -36.09%108M | 11.81%142M | 14.29%120M | 16.80%146M | 23.12%526M | 140.40%169M | 8.31%127M |
Income before tax | 30.95%2.86B | 10.73%2.05B | 11.91%6.67B | -13.67%1.16B | 33.09%2.18B | 7.50%1.48B | 15.37%1.85B | -5.00%5.96B | -15.78%1.34B | 1.61%1.64B |
Income tax | 30.42%909M | 8.06%657M | 7.40%2.12B | -25.22%338M | 29.80%697M | 10.16%477M | 10.14%608M | -5.84%1.97B | -12.82%452M | -8.74%537M |
Net income | 31.12%1.95B | 12.05%1.4B | 14.12%4.55B | -7.89%817M | 34.78%1.49B | 6.27%1B | 18.01%1.25B | -4.58%3.99B | -17.21%887M | 7.55%1.1B |
Net income continuous operations | 31.20%1.95B | 12.04%1.4B | 14.15%4.55B | -7.78%818M | 34.69%1.49B | 6.27%1B | 18.10%1.25B | -4.58%3.99B | -17.21%887M | 7.55%1.1B |
Noncontrolling interests | -18.75%13M | -60.00%6M | 2.17%47M | -50.00%5M | -23.81%16M | 22.22%11M | 150.00%15M | 61.10%46M | 349.44%10M | 72.37%21M |
Net income attributable to the company | 31.75%1.94B | 12.85%1.39B | 14.26%4.5B | -7.40%813M | 35.83%1.47B | 6.12%989M | 17.37%1.23B | -5.03%3.94B | -17.88%878M | 6.77%1.08B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 31.75%1.94B | 12.85%1.39B | 14.26%4.5B | -7.40%813M | 35.83%1.47B | 6.12%989M | 17.37%1.23B | -5.03%3.94B | -17.88%878M | 6.77%1.08B |
Gross dividend payment | ||||||||||
Basic earnings per share | 31.73%35.12 | 12.88%25.15 | 14.24%81.57 | -7.54%14.71 | 35.88%26.66 | 6.16%17.92 | 17.32%22.28 | -5.02%71.4 | -17.86%15.91 | 6.80%19.62 |
Diluted earnings per share | 31.77%35.1116 | 12.88%25.15 | 14.24%81.57 | -7.51%14.71 | 35.83%26.6467 | 6.13%17.9154 | 17.32%22.28 | -5.02%71.4 | -17.88%15.9046 | 6.79%19.6181 |
Dividend per share | 0 | 0 | 25.00%20 | 37.50%11 | 0 | 12.50%9 | 0 | 0.00%16 | 0.00%8 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |